论文部分内容阅读
目的 观察参芪扶正注射液对卵巢癌术后化疗减毒、改善临床症状、提高生存质量的疗效。方法 将 65例卵巢癌术后患者随机分为研究组(30例)和对照组(35例)。研究组采用化疗加用参芪扶正注射液,对照组单用化疗。观察两组患者KPS评分、改善临床症状、周围血象变化及参芪扶正注射液的不良反应。结果 研究组在KPS评分、临床症状、保护化疗后周围血象方面均优于对照组,差异具有统计学意义,P<0. 05,且无明显不良反应。结论 参芪扶正注射液配合卵巢癌术后化疗能减轻化疗药物的毒副反应,且能改善临床症状,提高生存质量。
Objective To observe the effect of Shenqi Fuzheng injection on attenuating ovarian cancer after chemotherapy, improving clinical symptoms and improving quality of life. Methods 65 cases of postoperative ovarian cancer patients were randomly divided into study group (30 cases) and control group (35 cases). The study group with chemotherapy plus Shenqi Fuzheng injection, the control group chemotherapy alone. KPS scores were observed in two groups to improve the clinical symptoms, peripheral blood changes and Shenqi Fuzheng injection adverse reactions. Results The study group was better than the control group in the KPS score, clinical symptoms and the protection of peripheral blood after chemotherapy, the difference was statistically significant, P <0.05, and no significant adverse reactions. Conclusion Shenqi Fuzheng injection combined with ovarian cancer chemotherapy can reduce the side effects of chemotherapy drugs, and can improve clinical symptoms and improve the quality of life.